Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

53.78
+0.86611.64%
Post-market: 53.940.1559+0.29%17:40 EDT
Volume:10K
Turnover:512.26K
Market Cap:51.09M
PE:- -
High:54.55
Open:54.51
Low:52.56
Close:52.91
52wk High:56.18
52wk Low:22.83
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.41
T/O Rate:1.01%
Dividend:0.65
Dividend Rate:1.21%
ROE:--
ROA:--
PB:1.16
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
ARCA
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.